Signaling mechanisms, interaction partners, and target genes of STAT6

被引:245
作者
Hebenstreit, Daniel [1 ]
Wirnsberger, Gerald [1 ]
Horejs-Hoeck, Jutta [1 ]
Duschl, Albert [1 ]
机构
[1] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria
基金
奥地利科学基金会;
关键词
STAT6; IL-4; IL-13; T(H)2; transcription factor;
D O I
10.1016/j.cytogfr.2006.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Like other members of the signal transducer and activator of transcription (STAT) family of proteins, STAT6 has a dual role as signaling molecule and transcription factor. STAT6 is tightly connected to IL-4 and IL- 13 signaling, and plays a key role in T(H)2 polarization of the immune system, as studies on knockout mice have illustrated impressively. The last 5 years have yielded many new insights into various aspects of STAT6 signaling. While the canonical view of STAT6 activation and biology remains largely unaltered, significant progress has been made in the identification of factors involved in STAT6 activity and STAT6-niediated gene regulation. About 35 different STAT6 target genes have been identified to date, many of which are involved in T(H)2-associated processes. This review summarizes the existing data on STAT6. Older landmark studies are discussed, as well as surprising recent additions, like hints oil inactive STAT6 dimers and the discovery of novel STAT6 isoforms. There is a particular focus on molecular aspects such as modifications of STAT6 and regulation of STAT6-dependent genes, since studies on these aspects have been particularly fruitful during the last few years. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:173 / 188
页数:16
相关论文
共 186 条
[91]   Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression [J].
Masuda, A ;
Matsuguchi, T ;
Yamaki, K ;
Hayakawa, T ;
Yoshikai, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26107-26113
[92]   Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation [J].
Mathew, A ;
MacLean, JA ;
DeHaan, E ;
Tager, AM ;
Green, FHY ;
Luster, AD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (09) :1087-1096
[93]  
Matsukura S, 1999, J IMMUNOL, V163, P6876
[94]   Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-α [J].
McBride, KM ;
Banninger, G ;
McDonald, C ;
Reich, NC .
EMBO JOURNAL, 2002, 21 (07) :1754-1763
[95]   Cooperation of the transcriptional coactivators CBP and p300 with Stat6 [J].
McDonald, C ;
Reich, NC .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (07) :711-722
[96]  
McHugh KP, 2001, J CELL BIOCHEM, V81, P320, DOI 10.1002/1097-4644(20010501)81:2<320::AID-JCB1047>3.0.CO
[97]  
2-M
[98]   Interleukin-15: a new cytokine target for the treatment of inflammatory diseases [J].
McInnes, IB ;
Gracie, JA .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) :392-397
[99]   Mutational analysis of the STAT6 SH2 domain [J].
Mikita, T ;
Daniel, C ;
Wu, PG ;
Schindler, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (28) :17634-17642
[100]  
Mikita T, 1998, J IMMUNOL, V161, P1822